Latest data from Philips reinforces the safety profile of Stellarex low-dose DCB

Sean Lyden, chairman of the Department of Vascular Surgery, Cleveland Clinic (Cleveland, USA), presented these data at 2019 Leipzig Interventional Course (LINC; 22–25 January, Leipzig, Germany) during a symposium focusing on the long-term safety of drug-eluting technologies in the leg. This latest data contrasts the findings of Katsanos et al's summary-level meta-analysis published in December 2018 reporting an increased risk of death at two and five years following the use of paclitaxel-c...

from A via a.sfakia on Inoreader http://bit.ly/2TvwOl3